This website uses cookies
Read our Privacy policy and Terms of use for more information.
LONGEVITY BIOTECH COMPANY EVALUATION
For investors and financial professionals who understand finance and want to understand biotechnology. Learn to examine the science, human evidence, valuation, cash runway, dilution, competition and next milestone using EverLife's 25-Gate Framework.
Free to join. No spam. Unsubscribe anytime.
No biology degree required. Educational training for independent research.
21 companies classified · 25 gates per company · 5 subsequent milestones verified · 1 financing-risk warning identified · Every original decision preserved
My background is in computer engineering and more than 25 years of building businesses and teams. My early longevity investments taught me how difficult it can be to compare exciting science, financing needs and development timelines. I developed a 25-criteria process that asks two connected questions: could the technology add meaningful lifespan or healthspan value, and do the company's economics justify further research? EverLife teaches that process through plain-English explanations, practical exercises and real company cases. The goal is to help you form your own research conclusion and recognize when specialist review is needed.
Explain a proposed treatment in plain English and separate a promising mechanism from evidence that a finished product works.
Recognize weak trial designs and unanswered questions. Examine ownership, cash runway, dilution and the assumptions behind a valuation.
Use a repeatable worksheet to record your assessment and the next trial, financing or regulatory milestone that could change it.
See what EverLife concluded, the evidence available at the time and what happened next. Original Scout and Tracker entries remain visible, including adverse developments. A research classification is not a holding, recommendation or investment-performance result.
Use each company case to practice answering:
What important problem is being addressed?
How is the technology supposed to solve it?
What has actually been demonstrated, from laboratory and animal evidence to controlled human results?
Which companies appear best positioned scientifically and financially?
What milestone could change the conclusion?
Learn The Process. Practice On Real Companies.
Read a free lesson to see how the science and investment questions fit together. The course teaches a consistent company-evaluation process through written modules, practical exercises and worked company assessments. Learn to test evidence, examine financing and valuation assumptions, and identify the milestone that could change your conclusion.
Explore The CourseLearn one useful biotechnology evaluation concept through an emerging technology or company each week.
Free to join. No spam. Unsubscribe anytime.